Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Missing the Opportunity to Fund FDA

This article was originally published in RPM Report

Executive Summary

NIH has seen its budget double during the Clinton and Bush Administrations, while FDA funding has remained essentially flat over the same period. It's time to correct the discrepancy.

You may also be interested in...



Nickel and Diming FDA

Everyone agrees FDA needs more money to do its job. Its not getting it. Does that mean the drug safety law will just end up making a bad situation worse?

Nickel and Diming FDA

Everyone agrees FDA needs more money to do its job. Its not getting it. Does that mean the drug safety law will just end up making a bad situation worse?

Dog Days for FDA: Agency Weathers a Stressful Spring

Drug withdrawals, Congressional hearings, travel restrictions-it is a stressful time to work at the Food & Drug Administration. Add a massive pet food recall. Is FDA going to the dogs?

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel